Dicot AB
Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It develops LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.
Dicot AB (DICOT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: -0.278x
Based on the latest financial reports, Dicot AB (DICOT) has a cash flow conversion efficiency ratio of -0.278x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-20.40 Million) by net assets (Skr73.40 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Dicot AB - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Dicot AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Dicot AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dicot AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SPARQ Corp.
OTCQB:SPRQF
|
-0.106x |
|
The BORN Korea
KO:475560
|
N/A |
|
SDCL EDGE Acquisition Corporation
NYSE:SEDA-UN
|
-0.009x |
|
IL Science Co. Ltd
KQ:307180
|
0.100x |
|
SKY Metals Ltd
AU:SKY
|
-0.041x |
|
VST Industries Limited
NSE:VSTIND
|
0.055x |
|
Calida Holding AG
SW:CALN
|
-0.009x |
|
Hot Chili Limited
OTCQX:HHLKF
|
-0.006x |
Annual Cash Flow Conversion Efficiency for Dicot AB (2021–2025)
The table below shows the annual cash flow conversion efficiency of Dicot AB from 2021 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr73.40 Million | Skr-85.80 Million | -1.169x | -121.62% |
| 2024-12-31 | Skr111.67 Million | Skr-58.90 Million | -0.527x | +48.23% |
| 2023-12-31 | Skr44.39 Million | Skr-45.23 Million | -1.019x | +81.63% |
| 2022-12-31 | Skr5.36 Million | Skr-29.71 Million | -5.546x | -507.88% |
| 2021-12-31 | Skr28.35 Million | Skr-25.87 Million | -0.912x | -- |